Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Llaneras

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Viral Hepatitis|December 2, 2016
Hepatitis C virus genotype 4: Genotype 1's little brotherJ Llaneras, M Riveiro-Barciela, M Buti, et al.
Journal of Viral Hepatitis|May 14, 2015
Therapy for hepatitis C genotype 3: moving forwardM Buti, J Llaneras, M Riveiro-Barciela, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 3, 2016
Removal from liver transplantation list of a hepatitis C virus-HIV co-infected patient after successful treatment with sofosbuvir and daclatasvirJ Llaneras, L Castells, B Santos, et al.
Journal of Viral Hepatitis|December 16, 2016
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infectionC Perelló, J A Carrión, B Ruiz-Antorán, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Viral Hepatitis|December 2, 2016
Hepatitis C virus genotype 4: Genotype 1's little brotherJ Llaneras, M Riveiro-Barciela, M Buti, et al.
Journal of Viral Hepatitis|May 14, 2015
Therapy for hepatitis C genotype 3: moving forwardM Buti, J Llaneras, M Riveiro-Barciela, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 3, 2016
Removal from liver transplantation list of a hepatitis C virus-HIV co-infected patient after successful treatment with sofosbuvir and daclatasvirJ Llaneras, L Castells, B Santos, et al.
Journal of Viral Hepatitis|December 16, 2016
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infectionC Perelló, J A Carrión, B Ruiz-Antorán, et al.
Pageof 1